Seattle scientists make progress on cure for genital herpes
Dr. Keith Jerome explained how dormant herpes infections can emerge “from this hiding place in the nerves... reactivate themselves and come back out, transmit to a new person or they can cause visible or sometimes painful lesions.”
COVID vaccine update: CDC now recommends second dose for older adults, immunocompromised
Dr. Larry Corey talked about the evolution of COVID noting, “The effects that the early vaccination had have long worn off, and the virus has escaped from them. The hope is double boosting will transfer your immunity.”
A viral gene drive could offer a new approach to fighting herpes
Drs. Keith Jerome and Marius Walter discussed their Nature Communications study on gene editing for herpes. Jerome explained his hope for a herpes cure: “You don’t ever have to worry about this virus again.”
What does it mean to be immunocompromised?
Fred Hutch patient Kaley Karaffa and Dr. Josh Hill explained how being immunocompromised impacts daily life. Karaffa said, “I had to become cautious about who I saw, the activities I was involved in and even the kind of food I ate.”
FDA authorizes updated COVID vaccines. Who should get the shot and when, according to experts
Dr. Larry Corey recommended everyone eligible for the COVID vaccine update get one. He said, “When we look at people who are currently hospitalized, they haven’t been boosted for a long time.”
AIDS crisis from 1980s to today: How Seattle responded with hope, healing
Ro Yoon and Dr. Larry Corey shared perspectives on HIV research, activism and public fatigue. Yoon emphasized the importance of keeping HIV “relevant to an audience that might not be aware of the long, hard history of activism.”
Herpes cure on the horizon
Dr. Keith Jerome discussed his team’s progress in developing a gene therapy for herpes simplex virus. He said, “There’s not a cure yet that everybody can go out and get, but we’re getting closer to a cure.”
Seattle virologists find promising new results for potential herpes cure
Dr. Keith Jerome described how his team’s herpes cure research could help people who want to be cured of their infection: “What we want to do is offer a tool that says if this really matters to you, we can help make your life better.”
The mouth microbe implicated in colorectal cancer
Dr. Chris Johnston described next steps for work published in Nature with Dr. Susan Bullman: “Because this bacterium is so intimately associated with cancers, it raises the question, ‘can we harness this?’ That’s something we’re very interested in.”
A new type of bacteria was found in 50% of colon cancers. Many were aggressive cases.
Dr. Susan Bullman explained a new Nature study she co-authored with Dr. Chris Johnston and how a specific subtype of bacterium helps tumor cells hide from therapies: “It acts like a cloak.” Many medical and health news outlets also covered the study.
COVID-19 vaccine in patients with hematologic cancer receiving HSCT or CAR-T therapy
Dr. Josh Hill pointed out the need for preventive COVID-19 therapies.
Miracles start in the lab: the quest to find a vaccine to cure AIDS
Dr. Larry Corey underscored that implementation of vaccines is important.
How immunocompromised experts are approaching the holidays
Dr. Steve Pergam gave practical guidance for managing risk of infection as an immunocompromised person.
Fred Hutch doctor outlines lessons learned during the pandemic
Dr. Larry Corey joined Jake Whittenberg for a bike ride and then sat down to discuss lessons learned during COVID.
In Seattle, Fauci talks COVID politics, monkeypox and life in the public eye
Highlights from Dr. Anthony Fauci and Dr. Larry Corey’s fireside chat was covered as well as the presentation of the honorary Hutch Award.
There’s still no HIV vaccine. The science behind coronavirus vaccines may help
Dr. Larry Corey compared the challenge of developing effective HIV vaccines with raising children.
New area eligibility for high-demand COVID-19 prevention drug
Dr. Catherine Liu and Rebecca Relyea, a patient, discussed a monoclonal antibody drug that prevents COVID in people who are immunocompromised.
COVID cases are up. Most mandates ended months ago. So where does WA stand?
Drs. Josh Schiffer and Trevor Bedford shared COVID-19 insights.
As COVID rates rise in Europe and Asia, how worried should Americans be about another wave?
Dr. Josh Schiffer reflected on the evolving nature of the pandemic.
As virus data mounts, the J&J vaccine holds its own
Dr. Larry Corey commented on longer-term immune data on the J&J COVID vaccine.
What health experts say about the ‘natural experiment’ of ditching mask mandates in WA
Dr. Josh Schiffer recommended a flexible approach to SARS-CoV-2 measures going forward.
COVID predictions? These experts are done with them
Drs. Josh Schiffer, Pavitra Roychoudhury and Trevor Bedford shared omicron insights.
Halting progress and happy progress: How mRNA vaccines were made
Drs. Elizabeth Halloran and Larry Corey described decades of scientific effort that led to COVID vaccines.
Omicron is spreading at lightning speed. Scientists are trying to figure out why
Dr. Josh Schiffer compared omicron to previous variants.
Healthy, boosted people unlikely to develop severe omicron infections, but jury’s out on older, at-risk populations
Dr. Larry Corey highlighted the strain on hospital systems.
How contagious is omicron? What does that mean for you?
Dr. Josh Schiffer characterized recent COVID variants.
A Guide to Mixed-Vaccination-Status Holidays
Dr. Larry Corey talked about the complexity of COVID, quarantines and young children.
Scientists in Washington researching COVID-19 Omicron variant to help protect public
Dr. Josh Schiffer described his concerns about omicron infections.
Dr. Larry Corey on the Omicron variant of COVID
Dr. Larry Corey answered viewer questions about omicron, including vaccine efficacy.
COVID-19 experts answer questions about Omicron -- and where the variant may have come from
Drs. Larry Corey and Pavitra Roycoudhury discussed the Omicron variant.
How bad will omicron be? Scientists won’t really know for months
Dr. Josh Schiffer noted that larger data sets are needed to understand omicron.
Treatments will change the pandemic, but they can’t end it alone
Dr. Larry Corey reflected on how COVID will change our response to respiratory illnesses.
COVID vaccines were rolled out 10 months ago in Washington state. Where do we stand now?
Dr. Larry Corey commented on measures enacted to fight COVID-19.
FDA clears first coronavirus vaccine for 5- to 11-year-olds
Dr. Larry Corey reflected on the FDA’s approval of Pfizer’s COVID vaccine in children.
Local doctors say children 5-11 years old could get vaccine by Thanksgiving
Dr. Larry Corey discussed when 5-11 year olds may receive the vaccine.
Can New Variants of the Coronavirus Keep Emerging?
Dr. Josh Schiffer discussed implications for immunity against COVID-19 as SARS-CoV-2 continues to mutate.
Yes, We’re Still Talking about Covid Vaccine Myths
Dr. Larry Corey underscored the safety of COVID vaccines.
Is There Another Reason Biden Likes Boosters?
Dr. Larry Corey commented on COVID vaccine boosters.
Analysis: U.S. hopes COVID vaccine boosters will decrease not just deaths, but virus spread
Dr. Larry Corey noted that vaccine boosters may prevent transmission.
Johnson & Johnson’s HIV vaccine fails first efficacy trial
Dr. Larry Corey characterized results from an HIV vaccine study he helped lead.
Many patients with cancer lack adequate immunity to measles, mumps
Dr. Steve Pergam and Elizabeth Krantz discussed their study on cancer patients and immunity to measles and mumps.
Q&A: Seattle COVID-19 vaccine expert answers questions about booster shots
Dr. Larry Corey discussed COVID vaccine boosters.
As Delta Surges, Covid-19 Breakthrough Cases Remain Uncommon
Dr. Larry Corey discussed breakthrough cases of COVID.
Why a fast-spreading coronavirus and a half-vaccinated public can be a recipe for disaster
Dr. Josh Schiffer discussed the rise of variants.
Patients With Cancer May Have an Increased Risk for Measles and Mumps
Dr. Steve Pergam and Elizabeth Krantz discussed their study on measles and mumps immunity in cancer patients.
Many People With Cancer Lack Protection Against Measles and Mumps
Dr. Steven Pergam and biostatistician Elizabeth Krantz discussed their research on cancer patients and immunity to mumps and measles.
Will COVID vaccine booster shots be needed? It's likely, experts say, but the immunocompromised should be prioritized.
Dr. Larry Corey commented on COVID vaccines in immunocompromised people.
Can we stretch existing Covid vaccines to inoculate more people? Experts are divided
Dr. Larry Corey expressed concern about using partial doses of COVID vaccines to increase global access to the vaccines without clinical data.
12 lessons COVID-19 taught us about developing vaccines during a pandemic
Dr. Larry Corey shared his reflections on the COVID vaccine program.
Study testing Moderna vaccine in transmission prevention to include young adults
Dr. Larry Corey commented on a study that is testing whether the Moderna COVID-19 vaccine works to prevent infection and transmission of the virus.
One year or five? Doctors and drug companies increasingly disagree about when we'll need COVID-19 booster shots
Dr. Larry Corey gave context around COVID vaccine efficacy and durability. He said, “If the duration of protection is such that you can still get a mild cold, but you don't end up in the hospital, the vaccine will still be a success.”
Who really needs coronavirus herd immunity? People with weakened immune systems
Drs. Josh Hill and Steve Pergam discussed COVID immunity among immunocompromised people. Dr. Hill pointed out that for those with weakened immune systems, “Antibody tests are just the tip of the iceberg of what the immune system is doing.”
Masks and social distancing may still be needed for people with compromised immunity
Dr. Josh Hill emphasized how broad COVID vaccination can “protect our vulnerable patient populations within the community who either can’t get vaccinated for some reason, or who may not have as good of a vaccine response.”
The race to avoid a possible "monster" COVID variant
Dr. Josh Schiffer stressed rapid vaccination.
Meet the Seattle doctor who Dr. Fauci trusted to help develop COVID-19 vaccines
Drs. Tony Fauci and Larry Corey reflected on their collaboration on HIV and COVID vaccines.
What the Recent HIV Vaccine Research Findings Really Mean
Dr. Larry Corey commented on the challenge of creating an effective HIV vaccine.
A vaccine study in college students will help determine when it’s safe to take masks off
Dr. Larry Corey explained one of the questions the Prevent COVID U study is designed to answer:
Researchers pursuing novel treatments for herpes infections and diabetes win STAT Madness
Drs. Keith Jerome and Martine Aubert won the annual STAT Madness contest for biomedical research.
NCCN Guidelines Urge Patients With Cancer to Get a COVID-19 Vaccine, Whichever is Available
In a Q&A, Dr. Steve Pergam discussed national guidelines on COVID vaccines in cancer patients.
Luck is essential for any successful coronavirus variant, study shows
Dr. Josh Schiffer explained his team’s latest analysis of how super-spreader events allow variants to become predominant and create new variants.
Do COVID-19 vaccines stop transmission? Top scientists are now recruiting thousands of college students to find out
Dr. Larry Corey discussed a new study to find out if COVID vaccines prevent transmission.
Disappointment and Hope From Two HIV Prevention Trials
Dr. Larry Corey characterized results from the Antibody Mediated Prevention studies, coordinated through the HIV Vaccine Trials Network, as “important proof of concept” in using antibody infusions to prevent HIV.
COVID-19 precautions shut down flu this season, but what will next winter bring?
Dr. Steve Pergam reflected on how public health measures helped reduce spread of other respiratory viruses.
Is it really time to roll back gathering restrictions? Some experts are optimistic about WA moving to Phase 3
Dr. Josh Schiffer discussed his computational modeling of COVID-19 and a potential fourth wave of infections.
We may never reach herd immunity on coronavirus — but it probably doesn’t matter
Drs. Larry Corey, Josh Schiffer and Trevor Bedford spoke with The Seattle Times about herd immunity.
The Coronavirus Is Plotting a Comeback. Here’s Our Chance to Stop It for Good.
Dr. Josh Schiffer provided context on how the new coronavirus variants makes modeling difficult.
Washington high schools return to play knowing the COVID-19 risks, but hopeful about safety protocols
Dr. Josh Hill cautioned that high school sports may be disrupted by COVID-19.
People of color are underrepresented in US vaccine trials, study finds
Drs. Steve Pergam and Michele Andrasik stressed the need for more diversity and inclusion in vaccine clinical trials.
The coronavirus is going to stick around forever. Get ready for the new normal.
Dr. Larry Corey gave his thoughts to Business Insider about SARS-CoV-2 becoming endemic.
Covid masks save lives. The CDC says double-masking may save more.
In an op-ed, Dr. Josh Schiffer advocated for increased masking to limit the COVID-19 pandemic.
South Africa suspends Oxford-AstraZeneca vaccine rollout after researchers report ‘minimal’ protection against coronavirus variant
Dr. Larry Corey gave his insight on the pause in rolling out the AstraZeneca vaccine in South Africa.
With COVID-19 vaccine in short supply, scramble is on for second shots
Dr. Steve Pergam explained why people should get their COVID-19 vaccines from the same provider.
Mutated virus may reinfect people already stricken once with covid-19, sparking debate and concerns
Dr. Larry Corey was quoted in The Washington Post on the potential for reinfection from some variants.
New COVID-19 prediction models forecast a potential fourth wave — and how to minimize it
Dr. Josh Schiffer shared his prediction of what the next wave of the coronavirus pandemic could look like.
If I have cancer, dementia or MS, should I get the Covid vaccine?
Dr. Catherine Liu commented on emerging recommendations for cancer patients receiving COVID-19 vaccines.
For the first time, researchers say infusions of antibodies can prevent HIV infection
Dr. Larry Corey reflected on results from the Antibody Mediated Prevention study.
We could know soon whether vaccines work against a scary new coronavirus variant
Dr. Larry Corey discussed the global significance of the upcoming Janssen vaccine trial results.
New strains of COVID swiftly moving through the US need careful watch, scientists say
Dr. Larry Corey stressed that to slow the spread of variants of concern, as we expand access to COVID-19 vaccines, “We have to do everything we can to decrease the risk of transmission and acquisition.”
Why You Should Still Wear A Mask And Avoid Crowds After Getting The COVID-19 Vaccine
Dr. Larry Corey discussed why COVID vaccine Phase 3 trials focused on finding out if the vaccines reduced severe disease and didn’t measure transmission.
Can You Still Spread Covid-19 After You Get Vaccinated?
Dr. Larry Corey commented on the limited data about whether COVID vaccines prevent transmission.
Cancer clinics confident in COVID-19 precautions to protect patients, survivors
Dr. Steve Pergam shared the importance of COVID-19 prevention measures for cancer patients.
Can vaccinated people still transmit COVID-19? The answer is key for herd immunity, research finds
Dr. Josh Schffer emphasized why it’s important to understand if COVID-19 vaccines prevent asymptomatic infections and transmissions.
FDA review clears path for second coronavirus vaccine, this one developed by Moderna
Dr. Larry Corey commented on the diverse populations that were enrolled in the Moderna vaccine study.
Q&A with Dr. Larry Corey: With a coronavirus vaccine on the way, clinical trials leader reflects on what’s next
Dr. Larry Corey underscored the benefit of COVID vaccines.
Questions remain about whether cancer patients should get vaccine
Dr. Josh Hill shared guidance for cancer patients and the COVID-19 vaccine.
Countdown to a Coronavirus Vaccine
The New Yorker gave updates on vaccine trials and the first vaccines to get emergency approval.
CDC release revised guidance for quarantine length
Dr. Josh Hill shared insight into the CDC’s new guidelines around quarantining after exposure to COVID-19.
The Covid-19 vaccines are a marvel of science. Here’s how we can make the best use of them
Dr. Larry Corey spoke about the challenge of continuing to test some COVID vaccines, even as effective ones emerge.
Fred Hutch virologist on Moderna ask for emergency vaccine use
Dr. Larry Corey characterized the latest data on Moderna’s COVID-19 vaccine candidate.
We don't know if the coronavirus vaccines can stop the virus from spreading, but top scientists are pitching a new trial that could figure that out
Dr. Larry Corey outlined a new plan to test if COVID-19 vaccines prevent infection.
Make the necessary sacrifices to avoid an unimaginable catastrophe
Dr. Josh Schiffer authored an opinion piece urging Americans to take proper COVID-19 measures.
The Race for a Coronavirus Vaccine Runs Through Fred Hutch
Dr. Larry Corey summarized the role Fred Hutch and the COVID-19 Prevention Network is playing during the pandemic.
MLS Cup playoffs begin as COVID-19 cases spike: Will postseason be finished safely outside a bubble?
Dr. Josh Schiffer detailed why the MLS may face more COVID-19 related cancellations.
Covid complicates Thanksgiving as families struggle to modify 2020 holiday plans
Dr. Steve Pergam stressed the need for families to rethink holiday gatherings during the COVID-19 pandemic.
Why It’s a Big Deal If the First Covid Vaccine Is ‘Genetic’
Dr. Larry Corey reflected on the speed of COVID-19 vaccine development.
Health workers worried about Halloween COVID-19 increases
Dr. Steve Pergam underscored the importance of taking COVID-19 precautions during the holidays.
Most influential people fight against COVID-19: Kathleen Neuzil and Larry Corey
Dr. Larry Corey touted the expertise Fred Hutch brings to coordinate COVID-19 vaccine trials.
Moderna’s coronavirus vaccine trial is fully enrolled, 37 percent of participants are minorities
Dr. Larry Corey reflected on full enrollment in the first Phase 3 vaccine trial.
5 questions ahead of this week's FDA meeting on coronavirus vaccines
Dr. Larry Corey discussed how the COVID-19 Prevention Trials Network has supported enrolling diverse populations into COVID-19 vaccine trials.
Against Covid-19, imperfect measures do the most good
In an op-ed piece, Dr. Josh Schiffer suggested COVID-19 strategies can be flawed but still effective in reducing transmission.
Monoclonal antibodies could fill the COVID-19 treatment gap until vaccines arrive — but at a cost
Drs. Shelly Karuna and Larry Corey commented on the potential of monoclonal antibodies to treat and prevent COVID-19.
Colds Nearly Vanished Under Lockdown. Now They’re Coming Back
Dr. Steve Pergam described how the COVID-19 pandemic could impact other infections.
New ads encourage minorities to participate in vaccine trials
Dr. Larry Corey discussed the importance of conducting vaccine trials to the highest scientific standards.
New ads encourage minorities to roll up their sleeves and participate in coronavirus vaccine trials
Dr. Larry Corey discussed the purpose of CoVPN’s national ad campaign.
Scientists use gene therapy to tackle oral herpes in mice
Dr. Keith Jerome discussed the importance of his new paper showing a 90% reduction of latent herpes virus.
One Meeting in Boston Seeded Tens of Thousands of Infections, Study Finds
Dr. Josh Schiffer provided outside commentary on a new study looking at a COVID-19 superspreading event in Boston.
Editing out herpes
Dr. Keith Jerome discussed his new study showing how gene editing removed 90% of herpes in mice.
Researchers Report Covid-19 Reinfection in Hong Kong
Dr. Josh Schiffer described the role T-cells play in COVID-19 immune responses.
Will Covid-19 vaccines be safe for children and pregnant women? The data, so far, are lacking
Dr. Larry Corey commented on how discussions are underway to include pregnant women and children in COVID-19 vaccine trials.
How to decide if you should get tested for Covid-19 before seeing friends and family
Dr. Steve Pergam raised concerns about how unnecessary COVID-19 testing could lead to negative behaviors.
Global virology star Dr. Larry Corey leads the hunt for a COVID-19 vaccine
A profile of Dr. Larry Corey and his role leading operations for the CoVPN.
How ‘super spreader’ events can fuel coronavirus transmission -
Dr. Josh Schiffer described how to prevent COVID-19 superspreader events
Why Herd Immunity Won't Save Us
Dr. Josh Schiffer shot down the idea of achieving natural herd immunity for COVID-19.
MLS will resume the regular season: What we know and what we don't
Dr. Steve Pergam raised concerns over MLS matches resuming.
Why the Coronavirus is More Likely to ‘Superspread’ Than the Flu
Dr. Josh Schiffer emphasized the importance of “superspreader” events and COVID-19.
America’s obesity epidemic threatens effectiveness of any COVID vaccine
Kaiser Health News explored issues of vaccine efficacy in obese individuals, quoting Dr. Larry Corey.
Do you want to be a vaccine volunteer?
Dr. Larry Corey explained aspects of participating in a COVID-19 vaccine trial.
2020 flu shot strategy: Get yours early in the season
Dr. Steve Pergam described the importance of getting flu shots, especially for protecting babies, older people and others with compromised immune systems.
Covid-19 testing delays create a public health nightmare as schools and workplaces try to reopen
Dr. Steve Pergam expressed concerns over COVID-19 testing and the impact on underrepresented populations.
Large U.S. COVID-19 vaccine trials will exclude pregnant women for now
Dr. Larry Corey emphasized the need for COVID vaccine data in pregnant women to find what is the safest vaccine for them.
Fred Hutchinson doctor overseeing all COVID-19 vaccine trials in phase 3
Dr. Larry Corey explained CoVPN’s focus on including people at most risk for COVID-19 in the vaccine trials, specifically minorities and people with comorbidities.
Virus vaccine put to final test in thousands of volunteers
Dr. Larry Corey discussed CoVPN trial enrollment goals in terms of reaching a diverse, multigenerational population.
Without a vaccine, researchers say, herd immunity may never be achieved
Dr. Joshua Schiffer predicted what may happen if the U.S. tries to achieve herd immunity without a COVID-19 vaccine.
The U.S. now has 4 million cases of coronavirus. As numbers continue to rise, what can be done now?
Dr. Steve Pergam weighed in on what we can do now to slow COVID-19, emphasizing physical distancing measures, PPE, test and tracing plans and masking.
Coronavirus antibody study will gauge prevalence of COVID-19 in Washington state
Keith Jerome’s antibody work and antibody study results from the Fred Hutch campus are discussed.
UK coronavirus vaccine prompts immune response in early test
Dr. Larry Corey’s comments saying a vaccine that is safe and works in at least 50% of people would be viable are discussed.
'You can beat the pandemic.' Former front-line workers share tips for coping with the COVID-19 surge
Dr. Steve Pergam shares tips to reduce the infection risk of COVID-19.
Moderna’s COVID-19 vaccine moves to bigger study
Dr. Larry Corey is mentioned for comments on the CoVPN registry, and the call for diverse trial participants.
Joel McHale and Ken Jeong look for light in the darkest timeline
Comedian Joel McHale spoke about his conversations on COVID-19 with Dr. Joshua Schiffer.
Decades of research on an HIV vaccine boosts the bid for one against coronavirus
Dr. Larry Corey discussed how building the HIV trial network laid the foundation for CoVPN.
More young people are getting — and spreading — the coronavirus
Dr. Joshua Schiffer commented on the trend of younger people getting COVID-19 and their risks.
Fred Hutch to lead COVID-19 vaccine trials
The CoVPN announcement is covered by KING 5.
Drugmakers will need to test their coronavirus vaccines in tens of thousands of people to see how well they work
Dr. Larry Corey discussed the CoVPN network, how the vaccine trials will be run and his role in the program.
Fred Hutch to coordinate large-scale vaccine trials for COVID-19 Prevention Network
Dr. Larry Corey discussed how the CoVPN trial network will work and the goals of the program.
COVID-19 vaccine trials now open to volunteers in U.S.
Forbes covered the CoVPN announcement and Fred Hutch’s role in the network of clinical trials.
Volunteers can now sign up for large coronavirus vaccine studies
Dr. Larry Corey commented on the role Fred Hutch will take in developing coronavirus vaccines, building off of work with HIV vaccines.
Here's how to volunteer for a COVID-19 vaccine trial
CNN covered the announcement of the CoVPN network, of which Fred Hutch will serve as the coordination center and Dr. Larry Corey as the lead.
The sports restart has a plan for everything—except a coronavirus outbreak
Dr. Steve Pergam commented on the restarting of professional sports in July, reinforcing that it may be necessary to stop if COVID-19 cases rise.
Public health officials do a reality check on Elon Musk’s tweets about COVID-19 tests
Dr. Keith Jerome and Trevor Bedford explained the rise in positive COVID-19 tests, indicating a rise in infections rather than false positives.
Treating cancer patients with COVID-19: A New York City experience
Dr. Catherine Liu commented on COVID-19 and cancer patients, and the risk for more severe infection.
Will Trump’s ‘Operation Warp Speed’ rush the science of a coronavirus vaccine?
Dr. Larry Corey explained ‘Operation Warp Speed’ for developing COVID-19 vaccines, and the safety and efficacy standards of the program.
Early data show no uptick in COVID-19 transmission from protests
Dr. Steve Pergam weighed in on the potential impact of reopening restaurants, loosening other restrictions, and protests on COVID-19 infection rates.
Seattle researcher advocates early COVID-19 testing and treatment
Dr. Joshua Schiffer’s new review paper, with co-authors from Fred Hutch and UW, suggesting that an early test and treat strategy is the best way to control COVID-19, is covered.
COVID-19 must be treated earlier to save lives, scientists advise
A review article by Dr. Joshua Schiffer on ways to keep COVID-19 from getting out of control again is covered, highlighting the need for widespread testing and treatment early in diagnosis.
Researchers want to pick up the pace on early testing and treatment for COVID-19
Dr. Joshua Schiffer’s new article emphasizing the need for widespread testing and early treatment for COVID-19 is discussed.
The enormous risks and stakes driving the NBA's safety discussions
Dr. Steve Pergam weighed in on the risks of starting up the NBA season during COVID-19.
As pressure for vaccine builds, regulators may face difficult decision
Dr. Larry Corey discussed COVID-19 vaccine trials and the challenges involved.
A coronavirus vaccine in 2020? Maybe. Here’s what has to go right
Dr. Larry Corey explained the complexities of COVID-19 vaccine trial setup and development.
Coronavirus vaccine candidates’ pivotal U.S. testing to start this summer
Dr. Larry Corey discussed COVID-19 vaccine trials, the timelines, and how they will be structured.
Everything will have to go 'perfectly' to have coronavirus vaccine by January, experts say
Dr. Larry Corey and Dr. John Mascola’s webinar on COVID-19 vaccine development is quoted, specifically that vaccine development will require coordination from all industries.
Vaccine veterans preview milestones on the long road to the end of the pandemic
A Fred Hutch webinar featuring Dr. Larry Corey and Dr. John Mascola of NIAID on COVID-19 vaccine development is recapped by GeekWire.
Airlines say it’s safe to travel. But is it?
Dr. Joshua Schiffer weighed in on the safety of travel during the COVID-19 pandemic, and possible ways to keep infection risk low.
UW expert: CDC ‘hopelessly compromised’ by White House in virus response
Dr. Steve Pergam commented on the need for public health to be driven by science and the value of the CDC.
Merck, one of Big Pharma’s biggest players, reveals its COVID-19 vaccine and therapy plans
Dr. Larry Corey is quoted on COVID-19 vaccine development progress.
Explainer: what do we now know about COVID-19 – and can you get it twice?
Dr. Joshua Schiffer weighed in on the possibility of reinfection with COVID-19.
Seattle researchers part of accelerated coronavirus vaccine testing program
Dr. Larry Corey suggested potential timeframes for the development of a COVID-19 vaccine.
Exclusive: U.S. plans massive coronavirus vaccine testing effort to meet year-end deadline
Dr. Larry Corey discussed the current status of COVID-19 vaccine trials.
Pandemic science speeds up — but there are limits
Dr. Joshua Schiffer weighed in on the possibility of reinfection with COVID-19, saying more research is needed.
HIV vaccine trials group steps up to the COVID-19 plate
Dr. Larry Corey is quoted for the announcement of COVID-19 vaccine trials.
Amazon wants to innovate its way out of the pandemic
Bloomberg cited the CovidWatch study as one of the ways Amazon is working to stop COVID-19.
Coronavirus investigated: Scaling vaccines
Dr. Larry Corey explained COVID-19 vaccine strategy and the current status of research around COVID-19 in this video interview with Science.
Bowman: Federal bureaucrats continue to ravage Washington’s coronavirus response
Dr. Steve Pergam commented on the shutdown of SCAN by the FDA.
The coronavirus is most infectious before people even know they have it, UW virologist says
Dr. Keith Jerome discussed COVID-19 virology, the possibility of reinfection, and transmission.
Fred Hutch study targets front-line workers most at risk from the coronavirus
The Covidwatch study is profiled, with Dr. Michael Boeckh explaining the study goals.
Is there a safe way to throw socially distanced shows?
Dr. Joshua Schiffer commented on the feasibility of staying safe from COVID-19 in large group gatherings such as concerts.
Fred Hutch recruits essential workers for COVID-19 study
KIRO 7 covered the CovidWatch program, led by Dr. Michael Boeckh, which aims to better understand COVID-19.
Coronavirus vaccine strategy: Larry Corey on the Long Run
Dr. Larry Corey discussed COVID-19 vaccine development and clinical trials.
To take on the coronavirus, U.S. vaccine makers consider an unprecedented strategy: working together
Dr. Larry Corey commented on COVID-19 vaccine trials and strategy.
NIH Director Francis Collins shares his best-case scenario for a coronavirus vaccine: We could have a shot by fall but mass-producing it will be 'a heck of a stretch' by the end of the year.
Business Insider referenced an editorial piece co-written by Drs. Larry Corey, Anthony Fauci and other experts on COVID-19 vaccine development.
Scanning for answers to a pandemic
The SCAN initiative is profiled by Gates Notes, mentioning Fred Hutch as a partner.
Bill Gates is funding a new at-home COVID-19 testing program and it's already testing 300 people a day
The SCAN initiative and Gates Notes article on the program are discussed.
Let’s say there’s a COVID-19 vaccine—Who gets it first?
Dr. Larry Corey’s co-authored editorial in Science, explaining a roadmap to a COVID-19 vaccine and calling for a variety of approaches and collaboration, is discussed.
14 percent of American adults would refuse coronavirus vaccine, poll finds
The Science piece co-authored by Drs. Larry Corey, Anthony Fauci, Francis Collins and John Mascola is cited.
Fauci and other experts outline COVID-19 vaccine strategy
Dr. Larry Corey is quoted on the need for collaboration and multiple COVID-19 vaccines, in relation to the release of a co-authored piece on COVID-19 vaccine development in Science.
Disease experts declare it’s time to join forces for multiple COVID-19 vaccines
GeekWire featured Dr. Larry Corey’s Science perspective, co-authored with Drs Anthony Fauci, John Mascola and Francis Collins, on proposed COVID-19 vaccine plans.
Essential workers asked to volunteer for coronavirus study
KOMO profiled the COVIDWatch study led by Dr. Michael Boeckh to track COVID-19 in the population.
Anthony Fauci, NIH director Collins say we’ll likely need more than one coronavirus vaccine to end pandemic
Dr. Larry Corey is discussed along with the co-authors Drs. Anthony Fauci, John Mascola and Francis Collins, on a Science perspective piece on the development of a COVID-19 vaccine.
Big decline in Wash. State coronavirus cases after 'stay home' orders
Dr. Keith Jerome is quoted on the impact that early physical distancing measures had in lowering COVID-19 rates in Washington.
Amazon lends its expertise — and its cash — to COVID-19 research
STAT covered the new COVIDWatch study and partnership with Amazon, aimed at learning more about COVID-19’s infection rate and if infection confers immunity.
Live updates: ‘Dangerous’ COVID-19 ‘parties’ begin to surface in Washington
Dr. Steve Pergam criticized those neglecting to follow physical distancing restrictions.
Why fully recovering from coronavirus might take longer than expected
Dr. Josh Schiffer explained the complexity of COVID-19 immune response and variability across patients.
How early COVID-19 detection sounded ‘tornado siren’ for WA response
Dr. Steve Pergam discussed the importance of early detection of COVID-19 in Washington’s virus response.
South Africa's HIV failures cost more than 300,000 lives. Now this painful past is helping in COVID-19 fight.
Dr. Larry Corey weighed in on the use of HIV ARV’s as potential treatments for COVID-19.
UPDATED: Datavant boots up a big COVID-19 registry — looking to shine a light on virus spread, impact and most effective therapies
Dr. Joshua Schiffer commented on a new COVID-19 patient registry to improve research efforts.
COVID-19 Q&A with experts
Dr. Joshua Schiffer is quoted on the use of hydroxychloroquine for COVID-19 treatment and the lack of understanding of its impact.
Saving a city: How Seattle’s corporate giants banded together to flatten the curve
Drs. Tom Lynch and Larry Corey recalled the start of the COVID-19 epidemic and discussed Fred Hutch’s efforts to track and control the virus along with other notable Seattle companies.
Risky business: Scientists seek volunteers for ‘CovidWatch’ virus-tracking study
GeekWire covered a new Fred Hutch study, Covidwatch, focused on those most at risk to get COVID-19, to help us better understand characteristics of the virus.
Have you recovered from COVID-19? The UW Medicine Virology Lab wants to test your blood
Drs. Larry Corey and Jesse Bloom discussed new COVID-19 antibody tests and research on neutralizing antibodies
Another sign the curve is bending: Positive coronavirus tests at UW peaked March 28
Larry Corey provided context to a new study from Fred Hutch and UW suggesting Washington state has successfully lowered COVID-19 infections through physical distancing measures.
Modified sleep apnea machines may ease the ventilator crunch
A study from Fred Hutch researchers on the use of ventilators in COVID-19 patients is cited.
COVID-19 and cancer: How to protect ‘the most vulnerable’ during pandemic
Dr. Steve Pergam commented on the increased susceptibility for COVID-19 within cancer patients, and how oncologists should prepare.
Before the flood
Dr. Steve Pergam, along with other first responders in the Seattle area, published a piece on the COVID-19 pandemic and outbreaks in Washington.
Blood tests promise to show who had COVID-19 and didn’t know it
Drs. Keith Jerome and Larry Corey explained work on blood tests for CoV-2 antibodies and the need for a vaccine.
How do COVID-19 deaths compare to flu deaths in Washington state?
Dr. Steve Pergam’s comments on how COVID-19 compares to the flu are included.
Infectious disease expert Steve Pergam shares his prescription for a safe weekend get-together
GeekWire covered Dr. Steve Pergam’s live COVID-19 Q&A, highlighting ways to stay safe but social.
COVID-19: What's happening now (April 1, 2020)
Dr. Gary Lyman and Dr. Michael Boeckh discussed patient care and safety during COVID-19, and the Cancer Care COVID-19 registry.
With record-setting speed, vaccine makers take their first shots at the new coronavirus
Dr. Larry Corey commented on the quick development of potential vaccines and vaccine trials for COVID-19.
As coronavirus spreads, Seattle scientists fast-track potential treatments for COVID-19
Dr. Larry Corey explained how the Seattle scientific community is stepping up to tackle COVID-19.
The Seattle scientific community, mobilized
Dr. Kristin Anderson wrote about the researchers in Seattle who are working together to study and combat COVID-19, including Drs. Keith Jerome, Alex Greninger and Trevor Bedford.
How does the coronavirus behave inside a patient?
Dr. Joshua Schiffer and Bryan Mayer discussed viral load variability in patients and what that could mean for COVID-19.
COVID-19 poses special challenges to cancer care
Drs. Steve Pergam and Masumi Ueda gave expert advice on treating cancer patients during the COVID-19 pandemic.
Fred Hutch researcher: ‘We need facts from experts’ in coronavirus briefings
Dr. Steve Pergam called for more scientific involvement in decisions around COVID-19 containment.
How to navigate cancer in the wake of the COVID-19 pandemic
Dr. Steve Pergam gave insight on the risk of cancer patients for COVID-19 infection.
Why social distancing is so hard – and so important
Dr. Steve Pergam provided crucial advice on social distancing and the role it plays in preventing COVID-19 spread.
COVID-19 and cancer
Dr. Steve Pergam gave Healio in depth advice to cancer patients to protect themselves from COVID-19.
Why Washington state is at the center of the US coronavirus outbreak
Dr. Keith Jerome’s COVID-19 test kit and the development of UW’s testing facilities are discussed.
Coronavirus hot zone: Research and responses in the U.S. epicenter
Dr. Steve Pergam is interviewed on COVID-19 and the risk to immunocompromised people.
The etiquette of social distancing in the time of coronavirus, from the ‘Miss Manners’ of germs
Dr. Steve Pergam, an infectious disease expert, provided commentary on social distancing in light of COVID-19.
Is your cancer center ready for COVID-19?
Dr. Steve Pergam provided expert commentary for cancer patients in light of COVID-19 and increased risk.
Microbiome predicts blood-cell transplant success
David Fredricks commented on outcomes of a large, international study showing that the microbiome predicts transplant success.
Why older and chronically ill Americans are at greatest risk from coronavirus
Dr. Steve Pergam comments on COVID-19 risk for cancer patients.
Cancer patients and coronavirus: Here's everything to know
Dr. Steve Pergam is quoted on his advice for cancer patients in light of increased risk for COVID-19.
The race to unravel the United States’ biggest coronavirus outbreak
Seattle Flu Study is profiled, delving into Drs. Keith Jerome, Helen Chu and Trevor Bedford’s research on COVID19 genetic analysis and vaccine development.
Exclusive: The strongest evidence yet that America is botching coronavirus testing
Virologist Dr. Keith Jerome’s COVID-19 testing kit is discussed, along with Trevor Bedford’s computational analysis of COVID-19 spread.
UW Medicine gets green light to test for coronavirus
Dr. Keith Jerome, a virologist, provided commentary on his new COVID-19 testing kit at UW Medicine.
What people with HIV need to know about the new coronavirus
Infectious disease expert Dr. Steve Pergam comments on what people with HIV need to know about COVID-19
What people with cancer need to know about the new coronavirus
Dr. Steve Pergam, an infectious disease expert, provided insight on COVID-19 risk for cancer patients.
Vaginal fluid transplants hold promise but raise safety concerns
Dr. David Fredricks, a microbiome researcher, provided expert commentary on vaginal microbiota transplantation.
Vaginal fluid transplants hold promise but raise safety concerns
Dr. David Fredricks, a microbiome researcher, provided expert commentary on vaginal microbiota transplantation.
London man seems to be free of HIV in second such case
Fred Hutch virologist Dr. Keith Jerome provided expert commentary about the second person who reportedly has been cured of HIV.
London man seems to be free of HIV in second such case
Fred Hutch virologist Dr. Keith Jerome provided expert commentary about the second person who reportedly has been cured of HIV.
Ten years after the ‘Berlin patient,’ doctors announce a second person has been effectively ‘cured’ of HIV
Fred Hutch virologist Dr. Keith Jerome provided context around news of the second person who reportedly has been cured of HIV. He commented, “Now there’s not one, but two people that others living with HIV can look toward for encouragement.”
Ten years after the ‘Berlin patient,’ doctors announce a second person has been effectively ‘cured’ of HIV
Fred Hutch virologist Dr. Keith Jerome provided context around news of the second person who reportedly has been cured of HIV. He commented, “Now there’s not one, but two people that others living with HIV can look toward for encouragement.”
Why gene editing may hold the promise of a herpes cure
Dr. Keith Jerome is featured in a story of research progress in treating herpes. He explains how his work with the gene editing tool – a class of enzymes called meganucleases – is showing more success in getting rid of the virus.
Why gene editing may hold the promise of a herpes cure
Dr. Keith Jerome is featured in a story of research progress in treating herpes. He explains how his work with the gene editing tool – a class of enzymes called meganucleases – is showing more success in getting rid of the virus.
Seattle’s HIV Hope
Fred Hutch researcher Drs. Keith Jerome, Hans-Peter Kiem and Michael Louella, who coordinates the research group’s Community Advisory Board, provide expert comments on the importance of community engagement in HIV research.
Seattle’s HIV Hope
Fred Hutch researcher Drs. Keith Jerome, Hans-Peter Kiem and Michael Louella, who coordinates the research group’s Community Advisory Board, provide expert comments on the importance of community engagement in HIV research.
Geek of the Week: Fred Hutch’s Steve Pergam caught a ’bug’ for infectious diseases and research
Fred Hutch researcher Dr. Steve Pergam is featured as GeekWire’s ‘Geek of the Week’. Dr. Pergam is an associate member of the Vaccine and Infectious Disease Division at Fred Hutch.
Geek of the Week: Fred Hutch’s Steve Pergam caught a ’bug’ for infectious diseases and research
Fred Hutch researcher Dr. Steve Pergam is featured as GeekWire’s ‘Geek of the Week’. Dr. Pergam is an associate member of the Vaccine and Infectious Disease Division at Fred Hutch.
Knowledge of benefits, harms of medical marijuana for cancer ‘far from complete’
Fred Hutch researcher Dr. Steve Pergam comments on cannabis use among cancer patients.
Knowledge of benefits, harms of medical marijuana for cancer ‘far from complete’
Fred Hutch researcher Dr. Steve Pergam comments on cannabis use among cancer patients.
World AIDS Day
This segment, which aired on the eve of World AIDS Day, covers local and global HIV vaccine trials led by Fred Hutch. It includes interviews with Drs. Janine Maenza, Larry Corey and an HIV study vaccine participant.
Majority of HIV persistence during ART due to infected cell proliferation
This article features a recent study by Fred Hutch Drs. Dan Reeves and Josh Schiffer that shows that a majority of the HIV-infected cells that persist in HIV-infected individuals even during suppressive antiretroviral therapy (ART) originate from cellular proliferation, not viral replication.
Majority of HIV persistence during ART due to infected cell proliferation
This article features a recent study by Fred Hutch Drs. Dan Reeves and Josh Schiffer that shows that a majority of the HIV-infected cells that persist in HIV-infected individuals even during suppressive antiretroviral therapy (ART) originate from cellular proliferation, not viral replication.
Can we gene-edit herpes away?
Dr. Keith Jerome, a virologist at Fred Hutch, co-authored a 2016 study about gene editing in herpes-infected mice. “His is the first study to show that gene-editing technology can reach the latent virus in a nerve cell, and the first to use that technology to damage some of the virus’ DNA,” according to a Smithsonian.com article on this and other efforts to combat the virus in humans.
Can we gene-edit herpes away?
Dr. Keith Jerome, a virologist at Fred Hutch, co-authored a 2016 study about gene editing in herpes-infected mice. “His is the first study to show that gene-editing technology can reach the latent virus in a nerve cell, and the first to use that technology to damage some of the virus’ DNA,” according to a Smithsonian.com article on this and other efforts to combat the virus in humans.
Fred Hutch researcher aims to cure HIV with 'ninja warrior' cells
Profile of Dr. Larry Corey and his research on how immunotherapy could be used to attack HIV and other viruses
Fred Hutch researcher aims to cure HIV with 'ninja warrior' cells
Profile of Dr. Larry Corey and his research on how immunotherapy could be used to attack HIV and other viruses
Could immunotherapy cure HIV? $2.6M grant will help Fred Hutch researcher find out
Article about a $2.6 million grant from Gilead Sciences to Dr. Larry Corey for HIV-cure research
Could immunotherapy cure HIV? $2.6M grant will help Fred Hutch researcher find out
Article about a $2.6 million grant from Gilead Sciences to Dr. Larry Corey for HIV-cure research
The elusive HIV vaccine: how Seattle scientists' frustration is turning to hope
Second in a two-part series about Fred Hutch's HIV vaccine research in South Africa quotes Dr. Larry Corey and Julie McElrath, among others
The elusive HIV vaccine: how Seattle scientists' frustration is turning to hope
Second in a two-part series about Fred Hutch's HIV vaccine research in South Africa quotes Dr. Larry Corey and Julie McElrath, among others
How vaginal bacteria could be stoking HIV cases and blocking prevention
Quotes Dr. David Fredricks, a microbiologist at the Hutch, in an article about how the vaginal microbiome might contribute to HIV risk
The elusive HIV vaccine: how Seattle scientists' frustration is turning to hope
Second in a two-part series about Fred Hutch's HIV vaccine research in South Africa quotes Dr. Larry Corey and Julie McElrath, among others
How vaginal bacteria could be stoking HIV cases and blocking prevention
Quotes Dr. David Fredricks, a microbiologist at the Hutch, in an article about how the vaginal microbiome might contribute to HIV risk
New HIV vaccine trial aims to build on earlier modest success
Article covers upcoming HIV Vaccine Trials Network large-scale trial, set to begin later this year, and quotes Dr. Larry Corey, president and director emeritus at Fred Hutch and principal investigator of the HVTN
New HIV vaccine trial aims to build on earlier modest success
Article covers upcoming HIV Vaccine Trials Network large-scale trial, set to begin later this year, and quotes Dr. Larry Corey, president and director emeritus at Fred Hutch and principal investigator of the HVTN
In pursuit of an HIV vaccine and the AIDS-free generation
Editorial by Fred Hutch HIV vaccine researcher and Director Emeritus Dr. Larry Corey and Nobel laureate Dr. David Baltimore of the California Institute of Technology
In pursuit of an HIV vaccine and the AIDS-free generation
Editorial by Fred Hutch HIV vaccine researcher and Director Emeritus Dr. Larry Corey and Nobel laureate Dr. David Baltimore of the California Institute of Technology
Seattle doctor featured on HBO's Vice for groundbreaking AIDS prevention
Fred Hutch virologist Dr. Larry Corey was interviewed about being featured in a VICE documentary on HBO, "Countdown to Zero," about the search for an HIV vaccine and cure.
World AIDS Day: See how much has changed in the fight against HIV/AIDS
Quotes Fred Hutch HIV vaccine researcher Dr. Larry Corey
Seattle doctor featured on HBO's Vice for groundbreaking AIDS prevention
Fred Hutch virologist Dr. Larry Corey was interviewed about being featured in a VICE documentary on HBO, "Countdown to Zero," about the search for an HIV vaccine and cure.
World AIDS Day: See how much has changed in the fight against HIV/AIDS
Quotes Fred Hutch HIV vaccine researcher Dr. Larry Corey